Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Tachycardia, clozapine effects Clozapine: common adverse effects Restarting clozapine after a break in treatment Blood pressure changes with antipsychotics Clozapine: serious cardiovascular adverse effects
Tapering benzodiazepines z-drugs/gabapentinoids antidepressants drug formulation problems
tardive dyskinesia (TD) 3 Extrapyramidal symptoms Stopping antipsychotics treatment Antipsychotic prophylaxis First-generation antipsychotics - place in therapy switching antipsychotics
Target ranges
Temazepam concentration in normal dosing and UK legal limit use in patients with renal impairment use in patients with hepatic impairment
Teratogenic potential carbamazepine mood stabilisers (eg valproate) 714 topiramate use in patients with renal impairment withdrawal effects antidepressants first generation antipsychotics second generation antipsychotics use in patients with hepatic impairment valproate
Test doses, long-acting injectable antipsychotics
Tetrabenazine
The alcohol-disulfiram reaction
Theophylline, safety in older patients/dementia
Therapeutic threshold
The use of lithium with clozapine.
thiamine deficiency (Wernickeâ™s encephalopathy), alcohol dependency
Thiazide diuretics, lithium interaction
Thrombocytopenia Clozapine: uncommon or unusual adverse effects Valproate 22q11.2 deletion syndrome Drug choice in breastfeeding
Thromboembolism Clozapine: uncommon or unusual adverse effects Venous thromboembolism Clozapine: serious cardiovascular adverse effects Menopause
Thyroid function tests, antipsychotic medication monitoring
Thyroxine in blood, psychotropic agent effects
tics and Touretteâ™s syndrome pharmacological treatments antipsychotics
Titration schedules Clozapine initiation schedules Initiation of clozapine in the community
Tolerance, dependence syndrome
Topical vaginal oestrogen or GSM treatment
Topiramate for antipsychotic-induced weight gain Alternatives to clozapine Negative symptoms
Torsades de pointes, methadone risk
Transaminases, drug induced increase in hepatic impairment
transcranial magnetic stimulation (TMS)
Transdermal patches equivalent doses nicotine antipsychotics maximum dose
Trazodone driving impairment in overdose smokers increased free plasma levels in hepatic impairment in pregnancy
Treatment algorithm for people not making an attempt to stop, i.e. those people temporarily abstaining or aiming to reduce their cigarette consumption.
Treatment of acute mania or hypomania.